UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma

Cancer letters, 2015-08, Vol.365 (1), p.107-111

2015

Volltextzugriff (PDF)

Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites

Molecular cancer therapeutics, 2008-07, Vol.7 (7), p.2080-2089

2008

Volltextzugriff (PDF)

Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine

Molecular cancer therapeutics, 2006-11, Vol.5 (11), p.2824-2833

2006

Volltextzugriff (PDF)

Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid

Cancer chemotherapy and pharmacology, 1998, Vol.41 (6), p.437-447

1998

Volltextzugriff (PDF)

Decreased Nucleotide Excision Repair Activity and Alterations of Topoisomerase IIα Are Associated with the in Vivo Resistance of a P388 Leukemia Subline to F11782, a Novel Catalytic Inhibitor of Topoisomerases I and II

Clinical cancer research, 2004-05, Vol.10 (9), p.3156-3168

2004

Volltextzugriff (PDF)

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo

Oncotarget, 2014-12, Vol.5 (24), p.12769-12787

2014

Volltextzugriff (PDF)

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer

Cancer letters, 2016-01, Vol.370 (1), p.10-18

2016

Volltextzugriff (PDF)

Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development

European journal of cancer (1990), 2006-11, Vol.42 (16), p.2821-2832

2006

Volltextzugriff (PDF)

Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system

Investigational new drugs, 2011-02, Vol.29 (1), p.9-21

2011

Volltextzugriff (PDF)

Vinflunine, the latest Vinca alkaloid in clinical development : A review of its preclinical anticancer properties

Critical reviews in oncology/hematology, 2001-11, Vol.40 (2), p.159-173

2001

Volltextzugriff (PDF)

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9845-9853

2008

Volltextzugriff (PDF)

Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines

Investigational new drugs, 2014-10, Vol.32 (5), p.883-892

2014

Volltextzugriff (PDF)

Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies

Seminars in oncology, 2008-06, Vol.35 (3 Suppl 3), p.S13-S21

2008

Volltextzugriff (PDF)

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

Oncotarget, 2011-11, Vol.2 (11), p.850-861

2011

Volltextzugriff (PDF)

99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation

European journal of nuclear medicine and molecular imaging, 2011-10, Vol.38 (10), p.1832-1841

2011

Volltextzugriff (PDF)

Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine

Investigational new drugs, 2008-08, Vol.26 (4), p.319-330

2008

Volltextzugriff (PDF)

Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase

Anti-cancer drugs, 2009-06, Vol.20 (5), p.364-372

2009

Volltextzugriff (PDF)

Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited

Critical reviews in oncology/hematology, 2000, Vol.33 (1), p.7-23

2000

Volltextzugriff (PDF)

Markedly diminished drug resistance-inducing properties of vinflunine (20', 20'-difluoro-3', 4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro

Cancer chemotherapy and pharmacology, 2001-07, Vol.48 (1), p.62-70

2001

Volltextzugriff (PDF)

Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents

Cancer chemotherapy and pharmacology, 2002-06, Vol.49 (6), p.479-486

2002

Volltextzugriff (PDF)

Vinflunine (20', 20'-difluoro-3', 4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro

Investigational new drugs, 1998-01, Vol.16 (1), p.3-17

1998

Volltextzugriff (PDF)

Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells

Anti-cancer drugs, 1999-07, Vol.10 (6), p.537-544

1999

Volltextzugriff (PDF)

Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II

Anticancer research, 2000-11, Vol.20 (6B), p.4557

2000

Volltextzugriff (PDF)

F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103

Cancer chemotherapy and pharmacology, 2000, Vol.46 (2), p.101-113

2000

Volltextzugriff (PDF)

Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action

Anti-cancer drugs, 2000-11, Vol.11 (10), p.829-841

2000

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Animals
(22)
Humans
(19)
Mice
(17)
Female
(14)
Vinblastine - Analogs & Derivatives
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Pharmacology & Pharmacy
(11)
Pharmacology. Drug Treatments
(11)
Vinblastine - Pharmacology
(11)
Antineoplastic Agents
(10)
Antineoplastic Agents, Phytogenic - Pharmacology
(9)
Cell Line, Tumor
(8)
Antineoplastic Agents - Pharmacology
(7)
Chemotherapy
(7)
Leukemia P388 - Drug Therapy
(7)
Tumor Cells, Cultured
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma

Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites

Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine

Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid

Decreased Nucleotide Excision Repair Activity and Alterations of Topoisomerase IIα Are Associated with the in Vivo Resistance of a P388 Leukemia Subline to F11782, a Novel Catalytic Inhibitor of Topoisomerases I and II

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer

Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development

Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system

Vinflunine, the latest Vinca alkaloid in clinical development : A review of its preclinical anticancer properties

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system

Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines

Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation

Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine

Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase

Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited

Markedly diminished drug resistance-inducing properties of vinflunine (20', 20'-difluoro-3', 4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro

Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents

Vinflunine (20', 20'-difluoro-3', 4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro

Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells

Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II

F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103

Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action

Aktive Filter

Suchergebnisse filtern